Randomized, open labelled, cross over deposition study of Tobramycin 100 PARI nebulized with eFlow® versus TOBI® nebulized with PARI LC PLUS® in subjects with CF Randomized, open labelled, cross over deposition study of Tobramycin 100 PARI nebulized with eFlow® ...
Randomized, open labelled, cross over deposition study of Tobramycin 100 PARI nebulized with eFlow® versus TOBI® nebulized with PARI LC PLUS® in subjects with CF Randomized, open labelled, cross over deposition study of Tobramycin 100 PARI nebulized with eFlow® ...
Cystic Fibrosis with Pseudomonas aeruginosa infection
Product Name: Tobramycin 100 PARI Product Code: T100 PARI INN or Proposed INN: Tobramycin Trade Name: TOBI® INN or Proposed INN: Tobramycin Product Name: Tobramycin 100 PARI Product Code: T100PARI INN or Proposed INN: Tobramycin Trade Name: TO ...
Randomized, open labeled, multi center, active controlled, parallel 28 days safety and bioavailability study of Tobramycin 100 PARI nebulized with eFlow® versus TOBI® nebulized with PARI LC PLUS in cystic fibrosis patients with Pseudomonas Aeruginosa infections Randomized, open labeled, multi center, active controlled, parallel 28 days safety and bioavailabili ...
Randomized, open labeled, multi center, active controlled, parallel 28 days safety and bioavailability study of Tobramycin 100 PARI nebulized with eFlow® versus TOBI® nebulized with PARI LC PLUS in cystic fibrosis patients with Pseudomonas Aeruginosa infections Randomized, open labeled, multi center, active controlled, parallel 28 days safety and bioavailabili ...
Product Name: Tobramycin 100 PARI Product Code: T100 PARI INN or Proposed INN: Tobramycin Trade Name: Tobi Product Name: TOBI® INN or Proposed INN: Tobramycin Product Name: Tobramycin 100 PARI Product Code: T100PARI INN or Proposed INN: Tobramycin Trade Name: To ...
A comparative, randomised, two period, multi-center, cross-over 14 weeksbioequivalence study of Tobramycin PARI (T100) versus TOBI® (Novartis) incystic fibrosis patients with bronchopulmonary chronic Pseudomonasaeruginosa infection - T-100 BE A comparative, randomised, two period, multi-center, cross-over 14 weeksbioequivalence study of Tobr ...
A comparative, randomised, two period, multi-center, cross-over 14 weeksbioequivalence study of Tobramycin PARI (T100) versus TOBI® (Novartis) incystic fibrosis patients with bronchopulmonary chronic Pseudomonasaeruginosa infection - T-100 BE A comparative, randomised, two period, multi-center, cross-over 14 weeksbioequivalence study of Tobr ...
Product Name: Tobramycin Product Code: T100 INN or Proposed INN: Tobramycin Other descriptive name: Tobramycinum Trade Name: TOBI® INN or Proposed INN: TOBRAMYCIN Product Name: Tobramycin Product Code: T100 INN or Proposed INN: Tobramycin Other descriptive name: Tob ...